from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3260c/whiB2

LFCtreatmentdescriptionclass of inhibitor

1.731

Amikacinug/mL Amikacintranslation

0.977

Cap5-10ug/mL Capreomycintranslation

1.384

Rox10-50 ug/mL Roxithromycintranslation

0.684

SM2-5 ug/mL Streptomycintranslation

1.018

Tet5-10 ug/mL Tetracyclinetranslation

-1.470

Rif0.2-5ug/mL Rifampicintranscription

-0.890

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.096

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.416

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.003

CPZ10-50 ug/mL Chlorpromazinerespiration

0.031

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.162

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.089

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.241

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.114

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.171

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.506

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.793

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.064

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.425

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.319

KCN5-20 ug/mL Potassium cyaniderespiration

-0.273

NaN30.2-2 mM Sodium aziderespiration

-0.726

Nigericin50 uM Nigericinrespiration

-1.195

TRC10-150 ug/mL Triclosanrespiration

-0.426

TRZ10-25 ug/mL Thioridazinerespiration

-0.212

Valinomycin0.5-10 uM Valinomycinrespiration

0.514

ZnSO42 mM ZnSO4respiration

-0.088

menadione6-10 ug/mL Menadionerespiration

-0.213

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.530

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.552

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.310

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.642

NRP_1Non-replicating persistence stage 1dosRassociated

1.232

Amp0.2mg/mL AmpicillincellWall

1.183

Cephalexin20-100 ug/mL CephalexincellWall

0.689

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.268

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.378

EMB10-20 ug/mL EthambutolcellWall

1.280

Eta12-40 ug/mL EthionamidecellWall

1.565

INH0.2-0.4 ug/mL IsoniazidcellWall

0.192

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.229

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.543

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.623

BZA0.12 mg/mL BenzamidearomaticAmides

0.081

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.549

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.203

H2O24 mM hydrogen peroxideDNAdamaging

-1.589

Levo10 ug/mL LevofloxacinDNAdamaging

-0.244

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.126

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.844

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.517

UVUV-irradiationDNAdamaging

0.316

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.582

Antimycin12.5-50 ug/mL Antimycin A?

0.226

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.735

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.640

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.003

PA8240.2-2 ug/mL PA-824?

0.660

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.026

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.243

Verapamil50 uM Verapamil?

-0.029

mercaptoethanol2 mM 2-Mercaptoethanol?

0.256

methoxatin10-20 ug/mL Methoxatin?